Fiera Capital Corp Has $1.04 Billion Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Fiera Capital Corp lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% in the third quarter, Holdings Channel.com reports. The fund owned 1,774,123 shares of the healthcare conglomerate’s stock after selling 31,156 shares during the quarter. UnitedHealth Group comprises 3.1% of Fiera Capital Corp’s holdings, making the stock its 7th largest holding. Fiera Capital Corp’s holdings in UnitedHealth Group were worth $1,037,294,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group during the 3rd quarter worth about $27,000. Macroview Investment Management LLC raised its position in UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the last quarter. Delos Wealth Advisors LLC raised its position in UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 53 shares during the last quarter. Bbjs Financial Advisors LLC acquired a new stake in UnitedHealth Group during the second quarter worth approximately $31,000. Finally, Global Wealth Strategies & Associates grew its stake in UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded up $9.97 during trading on Friday, reaching $615.42. The company had a trading volume of 993,978 shares, compared to its average volume of 3,892,864. The firm’s fifty day moving average is $581.13 and its 200 day moving average is $543.74. The firm has a market capitalization of $566.36 billion, a PE ratio of 40.01, a price-to-earnings-growth ratio of 1.75 and a beta of 0.58. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $617.44. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the previous year, the firm earned $6.56 EPS. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.36%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. Royal Bank of Canada dropped their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. HSBC lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. KeyCorp initiated coverage on UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price for the company. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 24th. Finally, Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.